About
Mendelics is the first and largest genomic analysis laboratory in Latin America, headquartered in São Paulo, Brazil. Founded to make genomic medicine accessible, it offers a comprehensive portfolio of genetic exams covering specialties such as oncology, cardiology, nephrology, neurology, dermatology, endocrinology, hematology, and more. Its flagship offering, the Mendelics Exome, is described as the most complete genetic exam with the highest diagnostic rate on the market. Other key products include hereditary cancer gene panels, the Bochechinha Test (analyzing over 300 diseases from a single cheek swab), carrier screening for recessive and X-linked diseases, and polygenic risk scores (PRS) for breast cancer. Mendelics uses a proprietary AI-powered software platform for genetic data analysis, which won the MIT innovation award, and maintains the largest database of Brazilian and Latin American genetic variants with over 100,000 exams performed. The lab is the only Brazilian genetics specialist to hold CAP, PALC, and ISO international accreditations. It is credentialed with Brazil's major health insurance providers and serves medical professionals, hospitals, clinics, and patients across the country. Mendelics bridges cutting-edge genomic science and clinical medicine by combining advanced NGS (next-generation sequencing) technology with intelligent bioinformatics to accelerate rare disease diagnosis and cancer risk assessment.
Key Features
- Comprehensive Exome Analysis: The Mendelics Exome exam provides the most complete genomic evaluation available, offering the highest diagnostic rate on the market for rare and complex diseases.
- AI-Powered Genetic Data Analysis: Proprietary software using artificial intelligence accelerates and improves the accuracy of genetic variant interpretation, recognized with the MIT innovation award.
- Hereditary Cancer Gene Panels: Standard-of-care NGS panels for hereditary cancer risk assessment, including breast cancer polygenic risk scores (PRS) and comprehensive hereditary cancer panels.
- Bochechinha Test: A non-invasive cheek swab test capable of screening for over 300 genetic diseases in a single exam, including carrier screening for recessive and X-linked conditions.
- Largest Latin American Variant Database: Over 100,000 genetic exams performed, building the most extensive database of Brazilian and Latin American genetic variants for more accurate, population-specific diagnoses.
Use Cases
- Diagnosing rare and undiagnosed genetic diseases through comprehensive exome sequencing for patients and physicians.
- Assessing hereditary cancer risk for patients with family history of breast, ovarian, colorectal, or other cancers using targeted NGS panels.
- Screening newborns and children for over 300 genetic conditions with a simple cheek swab via the Bochechinha Test.
- Evaluating carrier status for recessive and X-linked genetic conditions in prospective parents planning a family.
- Supporting nephrologists and oncologists with specialty-specific genetic panels to guide personalized treatment decisions.
Pros
- International Quality Certifications: The only Brazilian genetics laboratory holding CAP, PALC, and ISO certifications simultaneously, guaranteeing world-class diagnostic standards.
- Broad Health Insurance Coverage: Credentialed with Brazil's largest health insurance operators, making genomic testing accessible to a wide range of patients.
- Pioneer and Market Leader: As Latin America's first and largest genomic analysis lab, Mendelics brings unmatched expertise, infrastructure, and a validated track record in genomic medicine.
- AI-Accelerated Turnaround: Proprietary AI software streamlines report generation, delivering faster and more precise results compared to traditional manual analysis workflows.
Cons
- Primarily Brazil-Focused: Services and insurance partnerships are centered on the Brazilian market, limiting easy access for international patients or clinics outside Latin America.
- Requires Physical Sample Collection: Genetic testing requires biological sample submission (blood, cheek swab, etc.), meaning fully remote or digital-only access is not possible.
- Paid Service: While health insurance coverage is available, patients without qualifying plans must pay out-of-pocket, which may be a barrier for some individuals.
Frequently Asked Questions
What types of genetic tests does Mendelics offer?
Mendelics offers a wide range of genetic tests including exome analysis, hereditary cancer panels, genetic tests for nephrology, carrier screening for recessive and X-linked diseases, the Bochechinha Test (300+ diseases), polygenic risk scores for breast cancer, and NGS panels for repeat expansion disorders.
Does Mendelics accept health insurance?
Yes, Mendelics is credentialed with Brazil's major health insurance operators. You can contact them directly to verify if your specific plan covers the desired exam.
How does Mendelics use artificial intelligence?
Mendelics uses proprietary AI-powered software to analyze genetic data, interpret variants, and generate diagnostic reports more accurately and efficiently. This system won the MIT innovation award for its technological impact.
How is the genetic sample collected?
Depending on the exam, samples can be collected via blood draw or a simple cheek swab (bochechinha). Mendelics provides guidance on how to request and perform the collection from anywhere in Brazil.
What makes Mendelics different from other genetic labs?
Mendelics is the first and largest genomic analysis laboratory in Latin America, the only Brazilian genetics lab with CAP, PALC, and ISO certifications, and has the largest database of Brazilian and Latin American genetic variants — enabling more accurate, population-specific diagnoses.
